About 60 out of 100 000 articles are retracted after publication. Unfortunately, those who read or cite them are not always aware of their retracted status ➡ https://t.co/hE3d4tK62o
In 2024, a study using a British general practice database, linked to hospitalisation and mortality data, investigated several known adverse effects of neuroleptics in patients with dementia who were aged 50 years or older ➡ https://t.co/DUTgzeUEjM
Discover Prescrire International's Free Special Edition
Specially selected texts to introduce you to our wholly independent journal on drugs and health policy in Europe ➡ https://t.co/PKxqbZa4nR
📷 In the January issue of Prescrire International:
- RSV vaccines from 60 years of age
- Dupilumab better avoided in children with asthma
- An opportunity to transform the system of R&D incentives
This month's contents 📷 https://t.co/WmdXykNeXo
Receive the free, monthly Newsletter from the editors of Prescrire International, a critical eye on new drugs authorised in Europe. Sign up here ➡ https://t.co/9NCDoiApS5
The American Psychiatric Association (APA) has been producing successive versions of the Diagnostic and Statistical Manual of Mental Disorders (DSM) since 1952. The aim of the DSM is to propose a definition for every psychiatric disorder ➡ https://t.co/mT8mSBNpMz
🔎 In the october issue of Prescrire International:
- Finerenone in diabetic kidney disease?
- Carbamazephine during pregnancy: neurodevelopmental disorders
- Environmental impact of drugs
This month's contents ➡ https://t.co/f314Ps9YOT
In the interests of patients, Prescrire's contribution emphasises two points that are fundamental to the quality and safety of health care, and that the EMA must take into account while developing its forthcoming guideline on "non-inferiority" trials ➡ https://t.co/46DknUUly8